262 related articles for article (PubMed ID: 23922929)
1. Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin.
Morgan S; Lopes F; Gourley C; Anderson RA; Spears N
PLoS One; 2013; 8(7):e70117. PubMed ID: 23922929
[TBL] [Abstract][Full Text] [Related]
2. Ovarian damage from chemotherapy and current approaches to its protection.
Spears N; Lopes F; Stefansdottir A; Rossi V; De Felici M; Anderson RA; Klinger FG
Hum Reprod Update; 2019 Nov; 25(6):673-693. PubMed ID: 31600388
[TBL] [Abstract][Full Text] [Related]
3. C-Abl is not actıvated in DNA damage-induced and Tap63-mediated oocyte apoptosıs in human ovary.
Bildik G; Acılan C; Sahin GN; Karahuseyinoglu S; Oktem O
Cell Death Dis; 2018 Sep; 9(10):943. PubMed ID: 30237472
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of mangafodipir against chemotherapy-induced ovarian damage in mice.
Qin Y; Iwase A; Murase T; Bayasula ; Ishida C; Kato N; Nakamura T; Osuka S; Takikawa S; Goto M; Kotani T; Kikkawa F
Reprod Biol Endocrinol; 2018 Oct; 16(1):106. PubMed ID: 30368246
[TBL] [Abstract][Full Text] [Related]
5. Alleviation of endoplasmic reticulum stress protects against cisplatin-induced ovarian damage.
Wu Y; Ma C; Zhao H; Zhou Y; Chen Z; Wang L
Reprod Biol Endocrinol; 2018 Sep; 16(1):85. PubMed ID: 30176887
[TBL] [Abstract][Full Text] [Related]
6. Melatonin provides protection against cisplatin-induced ovarian damage and loss of fertility in mice.
Huang J; Shan W; Li N; Zhou B; Guo E; Xia M; Lu H; Wu Y; Chen J; Wang B; Xi L; Ma D; Chen G; Li K; Sun C
Reprod Biomed Online; 2021 Mar; 42(3):505-519. PubMed ID: 33388265
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin- and cyclophosphamide-induced primordial follicle depletion is caused by direct damage to oocytes.
Nguyen QN; Zerafa N; Liew SH; Findlay JK; Hickey M; Hutt KJ
Mol Hum Reprod; 2019 Aug; 25(8):433-444. PubMed ID: 30953068
[TBL] [Abstract][Full Text] [Related]
8. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure.
Pascuali N; Scotti L; Di Pietro M; Oubiña G; Bas D; May M; Gómez Muñoz A; Cuasnicú PS; Cohen DJ; Tesone M; Abramovich D; Parborell F
Hum Reprod; 2018 May; 33(5):844-859. PubMed ID: 29534229
[TBL] [Abstract][Full Text] [Related]
9. Acute doxorubicin insult in the mouse ovary is cell- and follicle-type dependent.
Roti Roti EC; Leisman SK; Abbott DH; Salih SM
PLoS One; 2012; 7(8):e42293. PubMed ID: 22876313
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin obliterates mouse ovarian reserve through both primordial follicle atresia and overactivation.
Wang Y; Liu M; Johnson SB; Yuan G; Arriba AK; Zubizarreta ME; Chatterjee S; Nagarkatti M; Nagarkatti P; Xiao S
Toxicol Appl Pharmacol; 2019 Oct; 381():114714. PubMed ID: 31437492
[TBL] [Abstract][Full Text] [Related]
11. Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility.
Nguyen QN; Zerafa N; Liew SH; Morgan FH; Strasser A; Scott CL; Findlay JK; Hickey M; Hutt KJ
Cell Death Dis; 2018 May; 9(6):618. PubMed ID: 29795269
[TBL] [Abstract][Full Text] [Related]
12. Rescue of platinum-damaged oocytes from programmed cell death through inactivation of the p53 family signaling network.
Kim SY; Cordeiro MH; Serna VA; Ebbert K; Butler LM; Sinha S; Mills AA; Woodruff TK; Kurita T
Cell Death Differ; 2013 Aug; 20(8):987-97. PubMed ID: 23598363
[TBL] [Abstract][Full Text] [Related]
13. Melatonin prevents cisplatin-induced primordial follicle loss via suppression of PTEN/AKT/FOXO3a pathway activation in the mouse ovary.
Jang H; Lee OH; Lee Y; Yoon H; Chang EM; Park M; Lee JW; Hong K; Kim JO; Kim NK; Ko JJ; Lee DR; Yoon TK; Lee WS; Choi Y
J Pineal Res; 2016 Apr; 60(3):336-47. PubMed ID: 26882203
[TBL] [Abstract][Full Text] [Related]
14. How do chemotherapeutic agents damage the ovary?
Morgan S; Anderson RA; Gourley C; Wallace WH; Spears N
Hum Reprod Update; 2012; 18(5):525-35. PubMed ID: 22647504
[TBL] [Abstract][Full Text] [Related]
15. The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation.
Winship AL; Griffiths M; Lliberos Requesens C; Sarma U; Phillips KA; Hutt KJ
Hum Reprod; 2020 Aug; 35(8):1864-1874. PubMed ID: 32604417
[TBL] [Abstract][Full Text] [Related]
16. Etoposide damages female germ cells in the developing ovary.
Stefansdottir A; Johnston ZC; Powles-Glover N; Anderson RA; Adams IR; Spears N
BMC Cancer; 2016 Aug; 16(1):482. PubMed ID: 27510889
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin-induced ovarian toxicity.
Ben-Aharon I; Bar-Joseph H; Tzarfaty G; Kuchinsky L; Rizel S; Stemmer SM; Shalgi R
Reprod Biol Endocrinol; 2010 Mar; 8():20. PubMed ID: 20202194
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin and cisplatin induce apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue.
Fabbri R; Macciocca M; Vicenti R; Paradisi R; Klinger FG; Pasquinelli G; Spisni E; Seracchioli R; Papi A
Future Oncol; 2016 Jul; 12(14):1699-711. PubMed ID: 27173589
[TBL] [Abstract][Full Text] [Related]
19. Non-growing follicle density is increased following adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy in the adult human ovary.
McLaughlin M; Kelsey TW; Wallace WH; Anderson RA; Telfer EE
Hum Reprod; 2017 Jan; 32(1):165-174. PubMed ID: 27923859
[TBL] [Abstract][Full Text] [Related]
20. Protective properties of glycogen synthase kinase-3 inhibition against doxorubicin-induced oxidative damage to mouse ovarian reserve.
Niringiyumukiza JD; Cai H; Chen L; Li Y; Wang L; Zhang M; Xu X; Xiang W
Biomed Pharmacother; 2019 Aug; 116():108963. PubMed ID: 31125824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
